Akanda Corp.
AKAN Healthcare Drug Manufacturers Specialty & Generic
Akanda Corp.’s revenue for fiscal 2025 (year ended December 2025) was $258,100.00, down 69.2% from fiscal 2024. Insiders bought in the last twelve months.
Follow AKAN
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Dec '24 | Jun '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+7 more quarters Free account |
3.84 | 2.53 | 0.50 | 0.76 |
Receivables |
0.82 | 0.99 | 1.40 | 1.66 | |
Other current assets |
0.39 | — | 1.70 | — | |
Total current assets |
5.06 | 3.57 | 3.60 | 2.80 | |
Property, Plant, Equpment (Net) |
2.37 | 2.44 | 7.72 | 3.48 | |
Goodwill and Intangible Assets (Total) |
0.02 | — | 0.00 | — | |
Long-term assets (Other) |
0.50 | — | — | — | |
Total non-current assets |
2.89 | 2.65 | 7.72 | 3.64 | |
Total Assets |
7.91 | 6.22 | 6.20 | 6.43 | |
Notes Payable |
— | — | 1.06 | 7.00 | |
Accounts Payable |
2.98 | 2.20 | 3.31 | 3.58 | |
Current Part of Debt |
0.35 | 0.18 | 1.01 | 1.03 | |
Current Part of Capital Lease |
0.00 | 0.14 | 0.19 | 0.12 | |
Current Part of Taxes to Pay |
0.00 | — | 0.00 | — | |
Other current liabilities |
0.30 | — | 0.64 | — | |
Total current liabilities |
3.64 | 2.84 | 6.20 | 12.48 | |
Long Term Debt (Total) |
— | 0.07 | 11.99 | 10.43 | |
Non-current Revenue (Deferred) |
0.00 | — | 0.00 | — | |
Minority Interests |
0.00 | — | 0.00 | — | |
Total non-current liabilities |
— | 0.07 | 11.99 | 10.43 | |
Total liabilities |
3.64 | 2.91 | 18.19 | 22.91 | |
Additional Paid In Capital |
0.00 | — | 0.00 | — | |
Preferred Stock (Total) |
0.00 | — | 0.00 | — | |
Common Stock (Net) |
63.32 | 63.64 | 94.61 | 95.92 | |
Retained Earnings |
(57.46) | (58.25) | (103.09) | (109.29) | |
Treasury Stock |
0.00 | — | 0.00 | — | |
Shareholders Equity (Other) |
(1.58) | 0.00 | (3.51) | 0.00 | |
Common Equity (Total) |
4.28 | 3.30 | (11.99) | (16.47) | |
Shareholders Equity (Total) |
4.28 | 3.30 | (11.99) | (16.47) | |
Shareholders Equity and Liabilities (Total) |
7.91 | 6.22 | 6.20 | 6.43 | |
Shares (Common) |
— | 0.03 | — | 0.53 | |
Shareholders Equity (Tangible) |
4.26 | 3.30 | (11.99) | (16.47) | |
Net Debt |
(3.49) | (2.27) | 12.49 | 10.70 | |
Total Debt |
0.35 | 0.26 | 12.99 | 11.45 |